3 completed, 2 enrolling by invitation, 2 recruiting, 1 unknown. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Enrolling by invitation 1, Recruiting 1 |
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow People Living With HIV: new trials by email Literature Review of People Living With HIV trials Research Report on People Living With HIV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease Digital nutritional program, Standard care dietary and exercice advice. - Metabolic Dysfunction-Associated Steatotic Liver Disease, People Living With HIV | Not applicable | Enrolling by invitation | Hospital Universitari de Bellvitge | 116 | 2025-04-23 | 2026-03-10 |
| reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA) reSET, Standard of care - Stimulant Use Disorder, People Living With HIV | Not applicable | Recruiting | University of Miami | 260 | 2025-03-04 | 2026-08-17 |
| RENEW-SHCS: Safety and Immunogenicity of a Recombinant HIV Env Protein Vaccine in ARV-treated Adults Living With HIV in the SHCS The Patients will all receive a vaccination with a recombinant HIV-1 envelope protein BG505 SOSIP.GT1.1 gp140 vaccine, adjuvanted,. - People Living With HIV, Antibody Response | Phase 1 | Enrolling by invitation | University of Zurich | 30 | 2025-02-25 | 2026-09-11 |
| COVID-19 Booster and IIV Schedule in Immunocompromised Hosts Inactivated influenza vaccine (IIV) at baseline, COVID-19 Vaccines at a 3-month interval, Inactivated influenza vaccine at Month 1 - COVID 19, Influenza | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 660 | 2024-11-20 | 2026-10-26 |
| Letermovir in ART-treated HIV-infected Persons Letermovir - People Living With HIV | Not applicable | Completed | Jean-Pierre Routy | 33 | 2022-09-26 | 2025-07-31 |
| A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago BHS+ORCHID - People Living With HIV | Not applicable | Completed | Northwestern University | 29 | 2021-10-15 | 2026-05-01 |
| Immunogenicity and Safety of COVID-19 Vaccine in People Living With HIV Coronavirus vaccine - People Living With HIV, COVID-19 | Phase 4 | Unknown | Beijing 302 Hospital | 200 | 2021-09-01 | 2021-10-20 |
| HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study Self-completion of a questionnaire - Men Who Have Sex With Men, People Living With HIV | Completed | ANRS, Emerging Infectious Diseases | 1048 | 2021-04-14 | 2022-07-22 |
COVID-19 (2) · Arthritis, Rheumatoid (1) · Homosexuality (1) · Inflammatory Bowel Diseases (1) · Influenza, Human (1) · Substance-Related Disorders (1)
Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Arthritis (1) · Autoimmune Diseases (1) · Behavior (1) · Chemically-Induced Disorders (1)
Standard of Care (1) · letermovir (1)
ANRS, Emerging Infectious Diseases (1) · Beijing 302 Hospital (1) · Hospital Universitari de Bellvitge (1) · Jean-Pierre Routy (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Northwestern University (1) · University of Miami (1) · University of Zurich (1)
Canada (2) · United States (2) · China (1) · France (1) · Spain (1) · Switzerland (1)
Alexandra Trkola, Prof. Dr. (1) · Carolina A Berini, BSc, PhD (1) · Jose Szapocznik, PhD (1) · Shu-juan Li, MD (1)
PMID 36690406, PMID 38487889, PMID 39334472, PMID 40163072
2025 (1), R01DA055563 (1)